[Gonadotrophin therapy (author's transl)].

Area of Science:

• Reproductive Endocrinology
• Andrology
• Infertility Research

Context:

• Optimizing outcomes in male infertility treatment requires precise patient selection.
• Gonadotrophins, such as human menopausal gonadotrophin (HMG) and human chorionic gonadotrophin (HCG), are used to treat infertility in men.
• Algorithmic approaches aid in excluding non-endocrine causes of infertility.

Purpose:

• To establish criteria for selecting male patients with severe oligozoospermia for gonadotrophin therapy.
• To evaluate the efficacy of gonadotrophin treatment in a cohort of carefully selected infertile men.
• To determine the impact of gonadotrophin-releasing hormone (GNRH) stimulation on hormonal profiles (FSH, LH, testosterone) in these patients.

Summary:

• A retrospective study analyzed 25 men with severe oligozoospermia selected using an algorithmic schedule.
• Hormonal levels (FSH, LH, testosterone) were measured before and after GNRH stimulation.
• The study identified specific criteria for successful gonadotrophin therapy in selected infertile males.

Impact:

• Provides a framework for selecting appropriate candidates for gonadotrophin treatment, potentially improving success rates.
• Contributes to a better understanding of the endocrine basis of male infertility and its management.
• Aids clinicians in making informed decisions regarding the use of gonadotrophins for male infertility.